Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection

BACKGROUND: The combination of boceprevir or telaprevir with peginterferon-alfa and ribavirin for the treatment of patients infected with HCV genotype 1 has led to significantly increased rates of sustained virological response (SVR) in phase III trials. There is only limited data regarding the safe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wehmeyer, Malte H, Eißing, Friederike, Jordan, Sabine, Röder, Claudia, Hennigs, Annette, Degen, Olaf, Hüfner, Anja, Hertling, Sandra, Schmiedel, Stefan, Sterneck, Martina, van Lunzen, Jan, Lohse, Ansgar W, zur Wiesch, Julian Schulze, Lüth, Stefan
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102246/
https://ncbi.nlm.nih.gov/pubmed/24884400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-14-87
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker